Changes in MTX-PG Concentrations During Subcutaneous MTX Therapy in Patients With Rheumatoid Arthritis(COSMOS Study)

Abroad (travel likely)RecruitingPHASE4

Conditions

Rheumatoid Arthritis (RA)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Keio University Hospital, Shinjuku-ku, Tokyo, Japan
Contact: Study coordinator (Yuko Kaneko) · ykaneko.z6@keio.jp · +81-3-5363-3786

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Efficacy and Safety of Resveratrol in Patients With Rheumatoid Arthritis.

Rheumatic Arthritis · Rheumatoid Arthritis (RA) Prevention · Inflamation

Abroad (travel likely)Recruiting

Cairo, Egypt

REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases

Rheumatoid Arthritis (RA) · Psoriatic Arthritis (PsA) · Axial Spondyloarthritis (AxSpA)

Abroad (travel likely)RecruitingPHASE4

Nijmegen, Netherlands · Maastricht, Netherlands

Advanced Therapeutics in Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

Abroad (travel likely)RecruitingPHASE4

London, Canada

Filgotinib Effect on Proteomic Profile and Micro-RNA Expression in Patients With Active Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

Abroad (travel likely)RecruitingPHASE4

Verona, Italy